In this Guardian “Global Development Professionals Network” blog post, Robert Steinglass, senior immunization adviser at John Snow, Inc., and immunization team leader for the USAID-funded Maternal and Child Health Integrated Program, writes about the importance of innovation to improving childhood immunization programs and health systems. He notes he recently moderated a panel at the GAVI Partners’ Forum, during which participants discussed different approaches.
Noting “[m]ultidrug-resistant organisms are showing up in top-flight hospitals” around the world, Carl Nathan, chair of the department of microbiology and immunology at Weill Cornell Medical College, writes in this New York Times opinion piece, “What makes the rapid loss of antibiotics to drug resistance particularly alarming is that we are failing to make new ones.” He continues, “We are emptying our medicine chest of the most important class of medicines we ever had. And the cause can be traced, for the most part, to two profound problems.”
“Each year, the United States spends more than $1.5 billion feeding starving people overseas,” columnist Farah Stockman writes in a Boston Globe opinion piece. “But our charity comes with a catch: The food has to be bought in America, and much of it must be shipped on American ships,” she continues, adding, “Researchers estimate that buying food closer to where needy people are costs about half as much.” She continues, “We are the last donor country in the world to have these rules,” and writes, “At a time of budget cuts, you would think that one thing Republicans and Democrats could agree on would be making sure every tax dollar stretches as far as it can.” Stockman asks, “Why don’t we just change it?”
Noting the recognition of International Human Rights Day on December 9, Purnima Mane, president and CEO of Pathfinder International, writes in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, “[E]very person should be able to make decisions about her or his body,” making reproductive rights a human rights issue. “From the London Summit on Family Planning supported by Melinda Gates, where thousands gathered to commit future investments in family planning, to Secretary of State Hillary Clinton’s strong advocacy to ensure U.S. leadership in global health that includes reproductive rights as human rights, to the work that’s happening on the ground in myriad countries around the globe to provide contraception, improve maternal health, ensure HIV prevention and treatment, and much more — progress is happening,” Mane writes, noting some of the barriers and challenges that remain in “[e]stablishing reproductive rights as human rights for all” (12/9).
“[W]e are losing the global fight against bad medicines,” and though “[s]ome progress is being made,” the “problem is that … crackdowns tend to focus on counterfeit drugs” while a “much bigger public health problem … is substandard drugs that are the result of shoddy manufacturing and handling — or perhaps worse, deliberate corner-cutting,” Roger Bate, a resident scholar at the American Enterprise Institute, writes in an opinion piece in The Hill’s “Congress Blog.” He continues, “In poor countries, a frightfully high number of bad drugs reach patients through legitimate supply chains and even donor programs underwritten by U.S. and European taxpayers,” increasing the risk of harm to patients and the development of drug-resistant disease strains.
Vaccines “save lives by protecting people against disease,” but they “also are an engine for economic growth — far beyond their health benefits,” GAVI Alliance CEO Seth Berkley writes in a CNN opinion piece. GAVI and its “many partners, including prominent companies,” “recognize that in addition to the humanitarian need, countries such as Tanzania are emerging markets that can fulfill their economic ambitions only if they also can ensure good health for their citizens,” he states. Berkley describes efforts to increase vaccination rates in Tanzania, and he writes, “[W]e know for a fact that vaccines — in addition to saving lives and improving health — are the cornerstone of a vibrant economy, fuel growth and serve as a magnet for foreign investment. Indeed, research has shown vaccines to be among the most cost-effective investments in global development.”
“After three decades of global emergency responses and a series of scientific breakthroughs in the fight against HIV/AIDS, it is now tempting to ask if we are marching towards the end of AIDS,” an editorial in the Lancet states. Noting the November 29 release of the U.S. Government’s PEPFAR Blueprint: Creating an AIDS-Free Generation, the Lancet writes, “The first and foremost signal the report has sent is that the U.S. commitment to the global AIDS response will continue to be ‘strong, comprehensive and driven by science,'” and the report “calls on partner countries, civil society, donors, foundations, multilateral institutions, and people living with HIV to step up together and make concrete commitments.” The editorial continues, “The vision of ‘an AIDS-free generation’ in the blueprint relies heavily on scientific and technological feasibility … However, eradicating a disease goes far beyond scientific advances, which will go unrealized without strong social support and public health actions as well as substantial and sustainable investments.”
The “progress and momentum” behind stopping mother-to-child HIV transmission is “reason to celebrate,” Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, and Peter Twyman, CEO of Keep a Child Alive, write in The Hill’s “Congress Blog.” However, “as we set our sights on an AIDS-free generation, we must once again ensure that children currently living with HIV are not left behind,” they state. “Unfortunately, we’re not seeing the same level of progress with access to services for children who are already living with the virus,” they write and describe the challenges children and their families face in gaining access to HIV treatment and care, including stigma and fear and a lack of antiretroviral drug formulations for children.
Chris Endean of the GAVI Alliance writes ahead of the GAVI Partners Forum in a CNN opinion piece about efforts to vaccinate members of the Maasai tribes in Tanzania’s Arusha National Park. Noting Maasai tribes are “constantly on the move searching for water and fresh pasture for their cattle,” he describes “severe logistical challenges” health workers face when trying to reach their patients and notes, “The need to get to hard-to-reach people like the Maasai and the rest of the estimated eight percent of Tanzania’s population that do not receive basic life-saving vaccines has taken on a new urgency with the country’s recent launch of a five-year development plan” called the “One Plan.” Endean notes the forum is taking place in the country’s capital, Dar es Salaam, and that during the event, “the health ministry will launch two new vaccines into the national immunization program — pneumococcal and rotavirus — tackling the primary causes of pneumonia and diarrhea — two of the leading killers of under-fives in Tanzania” (12/5).
Noting that the WHO’s Global Tuberculosis Report shows “that access to care and treatment for tuberculosis [TB] has expanded substantially in the past two decades,” Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in an AlertNet opinion piece, “Not only is this good news for those countries that are most vulnerable to tuberculosis; it is also good news for the global community,” as TB can be passed through the air. Derrick describes some of the interventions against TB instituted internationally, and she notes the Global Fund to Fight AIDS, Tuberculosis and Malaria “is the largest global donor to tuberculosis programs, providing 82 percent of international funding to fight the disease,” as well as “91 percent of international financing” to fight multidrug-resistant TB (MDR-TB).